|
|
Enzolytics Inc
OTC •
Healthcare •
Biotechnology •
Quote as of 05/08/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeOTC
Market Capitalization1.45 mln
Float4,831 mln
Earnings Date05/22/2026
Key Fundamentals
EPS-0.75
RPS0.22
ROA-705
EBITDA, mln-0.89
EV / EBITDA-0.26
Revenue, mln0.05
EV / Revenue4.89
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
50% |
98
/ 100
 |
| 1 Month |
20% |
84
/ 100
 |
| 2 Months |
9.09% |
65
/ 100
 |
| 6 Months |
50% |
80
/ 100
|
| 1 Year |
-33.33% |
18
/ 100
 |
|
| |
